Steatosis, oxidative stress, and apoptosis underlie the development of nonalcoholic steatohepatitis (NASH). Protein kinase C delta (PKCd) has been implicated in fatty liver disease and is activated in the methionine and choline-deficient (MCD) diet model of NASH, yet its pathophysiological importance towards steatohepatitis progression is uncertain. We therefore addressed the role of PKCd in the development of steatosis, inflammation, oxidative stress, apoptosis, and fibrosis in an animal model of NASH. We fed PKCd 2/2 mice and wildtype littermates a control or MCD diet. PKCd 2/2 primary hepatocytes were used to evaluate the direct effects of fatty acids on hepatocyte lipid metabolism gene expression. A reduction in hepatic steatosis and triglyceride levels were observed between wildtype and PKCd 2/2 mice fed the MCD diet. The hepatic expression of key regulators of b-oxidation and plasma triglyceride metabolism was significantly reduced in PKCd 2/2 mice and changes in serum triglyceride were blocked in PKCd 2/2 mice. MCD diet-induced hepatic oxidative stress and hepatocyte apoptosis were reduced in PKCd 2/2 mice. MCD diet-induced NADPH oxidase activity and p47 phox membrane translocation were blunted and blocked, respectively, in PKCd 2/2 mice. Expression of pro-apoptotic genes and caspase 3 and 9 cleavage in the liver of MCD diet fed PKCd 2/2 mice were blunted and blocked, respectively. Surprisingly, no differences in MCD diet-induced fibrosis or pro-fibrotic gene expression were observed in 8 week MCD diet fed PKCd 
Introduction
Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipids in the liver (steatosis) and may be a benign condition [1] . Its prevalence in the middle-aged segment of the population on a western diet is approximately 46% and of this group 30% are suggested to have non-alcoholic steatohepatitis (NASH) [2] . The prevalence of NAFLD in nonobese subjects has been reported to be 7.4% and 8.7% in the United States and India, respectively [3, 4] . The exact etiology for transformation of steatosis to NASH remains obscure; however, a classical ''two-hit'' hypothesis has been proposed to explain progression [5] . Steatosis constitutes the ''first hit.'' Proinflammatory cytokines (e.g. tumor necrosis factor-alpha, TNFa), oxidative stress, and lipid peroxidation constitute the ''second hit'' leading to NASH [1, 6] . Recently an alternative ''non triglyceride lipotoxicity'' hypothesis has been put forward implicating metabolites of free fatty acids in hepatocyte injury and development of NASH [7] .
The classical (a, b, and c) and novel (d, e, and h) protein kinase C (PKC) isoforms are intracellular signaling molecules activated by lipids [8] . Lipid infusion activates muscle and hepatic novel PKC isoforms (PKCd, PKCe, and PKCh) but not that of classical or atypical PKC isoforms [9] [10] [11] . The PKCd isoform can regulate lipid metabolism in the heart [12] and hepatic glucose production through a possible gut-brain-liver axis [13] , suggesting a role for PKCd in metabolic disease. Further, recent studies demonstrating that the PKCd isoform regulates high fat diet-induced hepatic steatosis and the expression of hepatic lipogenic genes [14, 15] suggest that PKCd plays an important role in lipid-associated liver disease.
Our recent studies in methionine and choline deficient (MCD) diet fed mice, which develop hepatic steatosis, inflammation, apoptosis, and fibrosis histologically similar to human NASH [16, 17] , demonstrated that PKCd protein expression and activation are elevated in the liver of mice fed the MCD diet compared to a control diet [18] . Furthermore, we observed in a cellular model of NASH that PKCd knockdown blocked JNK activation and blunted palmitate-induced apoptosis [18] . In the present study, we questioned the role of PKCd in regulating key pathophysiological features of NASH using the MCD diet model of NASH.
Materials and Methods

Animals
Heterozygous PKCd 2/+ mice in a mixed 129SX16C57BL/6 background were backcrossed up to six times with C57BL/6NHsd mice from Harlan Laboratories (Somerville, NJ) and then interbred to generate PKCd 2/2 mice and wildtype littermates (WT). PKCd genotyping was performed as previously described [19] . Mice were housed 2-4 per cage in Thoren units in the Bassett Research Institute, an AAALAC accredited animal facility, in light/dark (12L:12D), temperature 22uC, and humidity controlled rooms. Mice were provided with standard laboratory chow and water ad libitum. Six to eight week old PKCd +/+ and PKCd 2/2 mice (n = 6-8) were placed on a control or MCD diet (MP Biomedical, Cat #960441 or #960439, respectively) for four or eight weeks. No procedures were undertaken that caused more than minimal pain, distress, or discomfort. Mice were euthanized by inhalation of CO 2 . Blood and tissue samples were taken and processed as previously described [18] . This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Mary Imogene Bassett Hospital Institutional Animal Care and Use Committee (Protocol Number: 11-36).
Immunobloting and Antibodies
Frozen liver tissue was processed to generate total cell lysate extracts and membrane and cytosolic protein extracts as previously described [18, 20] . Polyclonal antibodies to phospho-PKCd (Thr505), phospho-PKCd (Ser643), phospho-PERK (Thr980), JNK1/2, caspase 9 (mouse specific), caspase 3, cleaved caspase 3 (Asp175), and monoclonal antibodies to phospho-JNK (Thr183/ Tyr185) and IRE1a were from Cell Signaling Technology (Danvers, MA). Rabbit monoclonal antibodies to p67 phox and p91 phox (NOX2) were from Epitomics (Burlingame, CA). Polyclonal antibodies to p24 phox and p47 phox were from EMD Millipore (Billerica, MA).
Polyclonal antibodies to PKCd (C-17), PKCe (C-15), PKCh (C-18), PKCa (C-20), and p22 phox and monoclonal antibodies to GAPDH (6C5) were from Santa Cruz Biotechnology (Santa Cruz, CA). A polyclonal antibody to calnexin and monoclonal antibody to PKCd were from Calbiochem/EMD Biosciences (La Jolla, CA). Monoclonal antibodies to atubulin and BiP/GRP78 were from Sigma-Aldrich (St. Louis, MO) and BD Biosciences (San Jose, CA), respectively. Goat anti-mouse and anti-rabbit peroxidase conjugated antibodies were from Sigma (St. Louis, MO). ECL Plus from GE Healthcare was used for detection.
Primary Hepatocyte Culture
Mice were anesthetized with an intraperitonal injection of pentobarbital (80 mg/kg). Perfusion was performed with welloxygenated, calcium free Hank's buffer containing 5 mM glucose, 1.5 mM Na lactate, 0.15 mM Na pyruvate, 0.1 mM EGTA, 10 mM HEPES, 100 IU/ml Penicillin and 0.1 mg/ml Streptomycin maintained at 37uC, followed by perfusion with 0.05% collagenase H (Roche, Indianapolis, IN) in low-glucose DMEM (Life Technologies Corporation, Carlsbad, CA) containing 10 mM HEPES, 40 mM NaHCO 3 and Pen/Strep. The hepatocytes were isolated from non-parenchymal cells using buffered Percoll and cultured in Waymouth's media (Life Technologies Corporation, Carlsbad, CA) containing 5% bovine growth serum for 2 h prior to treatment in serum free Waymouth's media for 18 h with BSAcomplexes of 0.4 mM of palmitate or oleate or BSA prepared as previously described [18] .
Liver Tissue Histological and Lipid Analysis
Paraffin embedded sections were stained with hematoxylin and eosin or Masson's trichrome and then examined in a blinded fashion by a board certified pathologist, grading for steatosis, inflammation, and fibrosis as previously described [18] . Sirius Red staining of paraffin embedded sections was scored in a blind fashion using the METAVIR scoring system [21] . Lipids were extracted from approximately 100 mg of ground frozen liver tissue as described by Bligh and Dyer [22] Triglycerides were assayed using a kit from Thermo Scientific (Rockford, IL) and normalized to the protein content measured using the BCA protein assay reagent (Thermo Scientific/Pierce, Rockford, IL).
Serum Metabolic Parameters
Alanine aminotransferase (ALT) and triglycerides were assayed as previously described [18] . Insulin was assayed using the Ultra Sensitive Mouse Insulin ELISA Kit from Crystal Chem Inc (Downers Grove, IL). NEFA was assayed using the kit from ZenBio, Inc. (Research Triangle Park, NC).
Liver Oxidative Stress Analysis
Liver samples were flash frozen and ground in liquid nitrogen. Ground tissue (50-100 mg) was homogenized on ice in PBS pH 7.4 buffer. The homogenate was tested for thiobarbituric acid reactive substances (TBARS) (ZeptoMetrix, Buffalo, NY) following manufacturer's instructions. Protein content was determined using the Pierce BCA Protein assay (Thermo Scientific/Pierce, Rockford, IL). TBARS units (nmoles/ml) were normalized to protein concentration. 4-Hydroxy-2-nonenal (4-HNE) staining was performed using a 4-HNE (HNE11-S) antibody (Alpha Diagnostics, San Antonio, TX). Five random fields per slide were scored and the results were determined from an average of those scores. NADPH oxidase activity was measured by the lucigenin enhanced chemiluminescence method. Briefly, fifty micrograms of membrane protein fractionated from frozen liver as previously described [18] was added to Krebs-Ringer buffer, pH 7.0, containing 1 mM EGTA, 150 mM sucrose, 5 mM lucigenin, and 100 mM NADPH. Photon emission in terms of relative light units was measured in a luminometer every 30 s for 5 min. There was no measurable activity in the absence of NADPH. Superoxide anion production was expressed as relative chemiluminescence (light) units (RLU)/mg protein. Protein content was measured using the BCA protein assay reagent (Thermo Scientific/Pierce, Rockford, IL).
Apoptosis Analysis
TUNEL positive cells were detected using the DeadEnd Fluorometric TUNEL system (Promega, Madison, WI) and the manufacturer's recommendations for controls. Propidium iodide (0.25 mg/ml) was used as the counterstain. An average score was generated based on a ratio of positive nuclei to total nuclei in 3 random fields.
RNA isolation and qRT-PCR
TRIZOL reagent (Sigma-Aldrich, St. Louis, MO) was used to isolate total RNA from frozen liver tissue and cultured primary hepatocytes. RNA quantity and quality was assessed using a bioanalyzer (Agilent 2100 Bioanalyze, Agilent Technologies, Santa Clara, CA) prior to reverse transcription using the RT 2 First Strand Kit (Qiagen, Valencia, CA). PCR was performed in 384 well plates with the RT 2 SYBR Green ROX qPCR Mastermix (Qiagen, Valencia, CA) with gene specific primers (SABiosciences, Fredrick, MD) using an Applied Biosystems 7900HT Sequence Detection System (Life Technologies Corporation, Carlsbad, CA) with a Corbett Robotics CAS-1200 precision liquid handling system for plate set-up. Melting curve analysis was performed to verify product purity. Threshold values of 0.023 and 0.02 were used for the analysis of liver and hepatocyte gene expression, respectively. GAPDH and the geometric mean of ACTB, GAPDH, GUSB, and HPRT were used to normalize DCt values for hepatocyte and liver gene expression, respectively.
Statistical analysis
All data are presented as the mean 61 standard error (S.E.). Statistical significance was determined by Student's t-test or the Mann-Whitney Rank Sum test (a = 0.05) or a one-or two-way repeated measures analysis of variance (a = 0.05) using the XLSTAT 2009 program (Addinsoft, New York, NY). Pair-wise comparisons were made using Tukey's test (a = 0.05).
Results
Effect of MCD diet on body and organ weights, serum metabolites and PKCd activation
We observed in a prior study that hepatic activation and protein content of PKCd, but not PKCa or PKCe, is elevated during the development of steatohepatitis in MCD diet fed mice [18] . To investigate the role of PKCd in the development of steatohepatitis in MCD diet fed mice, PKCd 2/2 mice and WT littermates were fed a control or MCD diet for four weeks. As expected PKCd protein expression was not detected in the liver of PKCd 2/2 mice fed a control or MCD diet (Fig. 1A ). In agreement with our previous study, hepatic activation and protein content of PKCd was elevated in MCD diet fed WT mice (data not shown). Consistent with the known effect of MCD diet feeding, WT and PKCd 2/2 mice lost body and liver weight, had lower serum levels of glucose and insulin, and higher serum levels of alanine aminotransferase (ALT) ( Table 1) . However, an ,50% reduction in serum levels of insulin in control fed PKCd 2/2 mice compared to control fed WT mice was observed. Interestingly, MCD dietinduced changes in fat pad weight and fat pad and liver weight normalized to body weight were not observed in PKCd 2/2 mice. Also, MCD diet-induced changes in serum triglyceride (TG) and non-esterified fatty acids (NEFA) were not observed in PKCd 2/2 mice. In contrast, no difference was observed in MCD dietinduced changes in serum levels of ALT in PKCd 2/2 mice. The changes in body and organ weights observed in female WT and PKCd 2/2 mice were similar to those in male mice ( Table 2 ), suggesting that the effect of the MCD diet was not sex dependent.
Effect of MCD diet on steatosis and lipid metabolism gene expression
Histological examination of livers from mice fed a MCD diet for four weeks showed a 30% reduction in steatosis in PKCd 2/2 mice compared to WT mice (p = 0.09) (Fig. 1B) . When steatosis was examined by frequency of the steatosis score (Fig. 1C) or by Correspondence Analysis (data not shown), the qualitative pattern of steatosis scores from PKCd 2/2 mice revealed clear differences compared to WT mice. Consistent with this result, a reduction in liver TG was observed in female and male PKCd 2/2 mice (69% and 61%, respectively) compared to WT mice ( Fig. 1C and 1D ). To determine whether hepatic genes involved in steatosis were differentially regulated in WT and PKCd 2/2 mice, we examined the effect of the MCD diet on hepatic genes involved in lipid metabolism. Stearoyl-coenzyme A desaturase 1 (SCD-1) gene expression was significantly decreased in both WT and PKCd 2/2 mice (Fig. 1F) . However, sterol-regulatory element binding protein-1 (SREBP-1) was significantly decreased only in MCD diet fed PKCd 2/2 mice but not WT mice. The expression of peroxisome proliferator-activated receptor a (PPARa), a key regulator of b-oxidation in mice, and its downstream target acylcoenzyme A oxidase (ACOX1), were significantly reduced in MCD diet fed PKCd 2/2 mice but not WT mice. Microsomal triglyceride transfer protein (MTTP) expression in MCD diet fed PKCd 2/2 mice was significantly reduced compared to control fed WT mice, yet was induced in MCD diet. Consistent with changes in MTTP expression, a significant reduction in gene expression of apolipoprotein (Apo) C-III, another key determinant of plasma triglyceride metabolism, was observed in MCD diet fed PKCd 2/2 mice but not WT mice, suggesting that secreted lipoproteins in PKCd 2/2 mice may be more efficiently lipolyzed. Because differences in steatosis, TG, and hepatic lipid metabolism gene expression were observed between WT and PKCd 2/2 mice, we questioned whether fatty acids may have a direct effect on lipid metabolism gene expression independent of a deficiency in methionine and choline. To address this question, we treated primary hepatocytes isolated from WT and PKCd 2/2 mice with control or fatty acid containing media and determined lipid metabolism gene expression. Oleate containing medium significantly increased the expression of SREBP-1 and SREBP-2 in hepatocytes from WT mice but not PKCd 2/2 mice (Fig. 1G ). Although the fatty acids had no effect on SCD-1 gene expression, a significant reduction in ACC1 was observed in oleate treated hepatocytes from WT mice but not PKCd 2/2 mice. Palmitate and oleate-induced Apo C-III expression in hepatocytes from WT mice was blocked and blunted, respectively, in hepatocytes from PKCd 2/2 mice. A significant reduction was observed in MTTP gene expression in oleate treated hepatocytes isolated from PKCd 2/2 mice but not WT mice. Taken together, these results are consistent with the hypothesis that PKCd plays a role in hepatic lipid metabolism.
Effect of MCD diet on histological scoring of inflammation and inflammation gene expression
Histological examination of livers from mice fed a MCD diet for four weeks showed an approximately 42% reduction in inflammation score in PKCd 2/2 mice compared to WT mice ( Fig. 2A) . However, no differences were found in the hepatic expression of TNFa, macrophage inflammatory protein 1 alpha (MIP1a/ CCL3), plasminogen activator inhibitor-1 (PAI-1), interleukin-1 alpha (IL1a), interleukin-1 beta (IL1b), pro-inflammatory genes or an anti-inflammatory gene, interleukin-10 (IL10), from MCD diet fed WT and PKCd 2/2 mice (Fig. 2B) .
Effect of MCD diet on markers of oxidative stress and oxidative stress gene expression Examination of livers from WT but not PKCd 2/2 mice fed a MCD diet showed significantly elevated staining for 4-HNE, a highly reactive aldehyde generated by the exposure of polyunsat- urated fatty acids to peroxides and reactive oxygen species (Fig. 3A) . Consistent with this result, the MCD diet-induced increase in TBARS in the liver of WT mice was blocked in PKCd 2/2 mice (Fig. 3B) . Genes involved in the generation of reactive oxygen species in the liver rose 2-fold in four week MCD diet fed WT mice (Fig. 3C, upper panel) and were significantly greater than 2-fold by eight weeks in MCD diet fed WT mice (Fig. 3C, lower panel) . In contrast, a significant reduction in the NADPH oxidase homolog (NOX4) was observed in MCD diet fed WT and PKCd 2/2 mice by eight weeks. Surprisingly, expression of NADPH oxidase (NOX2), p22 phox , p47 phox , and p67 phox were significantly elevated by four and eight weeks in the control diet fed PKCd 2/2 mice, while the MCD diet had no additional effect. NADPH expression in the liver at the protein level revealed that NOX2 protein expression was not affected in MCD diet fed WT and PKCd 2/2 mice at eight weeks (Fig. 3D) . In contrast, p67 phox was significantly increased in both WT and PKCd 2/2 mice fed the MCD diet for eight weeks. Consistent with the mRNA expression, significantly elevated expression of p22 phox and p47 phox protein was observed in control diet fed PKCd 2/2 mice. To determine the consequence of altered NADPH oxidase subunit expression, we assayed NADPH oxidase activity in the liver from eight week fed MCD mice. NADPH oxidase activity was strongly stimulated in WT mice fed the MCD diet and this activity was significantly reduced in PKCd 2/2 mice (Fig. 3E) . To gain insight into the mechanism by which MCD diet-stimulated hepatic NADPH oxidase activity was reduced in PKCd 2/2 mice, we determined the content of the NADPH oxidase organizing subunit p47 phox in membrane and cytosolic protein fractions. Translocation of p47 phox from the cytosol to the membrane where it interacts with p22 phox leads to NADPH oxidase activation [23] . A significant 84% increase in hepatic p47 phox membrane to cytosolic ratio was observed in WT mice fed the MCD diet. In contrast, hepatic p47 phox membrane to cytosolic ratio was not significantly increased in PKCd 2/2 mice (Fig. 3F) . As a control we investigated the membrane to cytosolic ratio of hepatic p22 phox . As expected, given that p22 is an integral membrane component of NADPH oxidase, no differences in the membrane to cytosolic ratio of hepatic p22 phox were observed.
Hepatic ER stress activation
Expression of IRE1a, Bip/GRP78, phospho-PERK, and phospho-JNK was examined in the livers from four week fed mice (Fig. S1 ). No effect of the MCD diet was observed on the hepatic protein levels of Bip/GRP78 in WT or PKCd 2/2 mice. In contrast, the MCD diet induced elevated levels of IRE1a and phospho-PERK in WT and PKCd 2/2 mice. A significant increase in phospho-JNK was observed in WT but not PKCd 2/2 mice fed the MCD diet. These data suggest that loss of PKCd may be involved in MCD diet-induced ER stress mediated by JNK.
Effect of MCD diet on cell death-cell cycle and apoptosis gene expression
Analysis of livers of WT mice fed the MCD diet for four weeks revealed a low number of TUNEL-positive hepatocytes which was reduced in livers from PKCd 2/2 mice (Fig. 4A, left panel) . In eight week MCD diet fed mice, the number of TUNEL-positive hepatocytes in WT mice was significantly increased to approximately 20%, while less than 10% of hepatocytes in the liver from PKCd 2/2 mice were TUNEL-positive (Fig. 4A, right panel) . Consistent with these results, MCD diet-induced caspase 3 and 9 cleavage (approximately 36% and 2-fold, respectively) in the livers from WT mice was completely blocked in livers from PKCd 2/2 mice (Fig. 4B, right panel) .
Analysis of cell cycle gene expression in the liver from WT mice fed the MCD diet for four and eight weeks revealed a significant elevation in Cyclin D1, Gadd45 and p21WAF in eight week fed mice (Fig. 4C) . Cyclin D1, p21WAF, and Gadd45 expression was also significantly elevated in eight week fed PKCd 2/2 mice. Further analysis of expression for genes regulating apoptosis revealed a significant decrease in Bcl6, Bnip3, and Fas in four week MCD fed PKCd 2/2 mice but not WT mice (Fig. 4D, left  panel) . In eight week MCD fed mice, Bcl6 expression was significantly reduced in only the WT mice (Fig. 4D, right panel) .
Effect of MCD diet on fibrosis and fibrosis gene expression
Trichrome and Sirius Red staining of livers from mice fed a MCD diet for eight weeks showed mild to moderate fibrosis in both WT and PKCd 2/2 mice ( Fig. 5A and 5B). To determine whether the mechanisms by which the MCD diet induced fibrosis were similar in WT and PKCd 2/2 mice, we examined the effect of the MCD diet on hepatic genes involved in fibrosis. Collagen (Type IIa2 and Type IIIa1), CCAAT-enhancer-binding protein beta (CEBPb), transforming growth factor beta (TGFb), and alpha smooth muscle actin (a-SMA) gene expression were significantly elevated in both MCD diet fed WT and PKCd 2/2 mice (Fig. 5C ), suggesting that MCD diet-induced fibrosis development was similar in WT and PKCd 2/2 mice.
Effect of MCD diet on PKC isoform gene expression and activation in WT and PKCd 2/2 mice
To determine whether gene expression of other PKC isoforms was affected in PKCd 2/2 mice, relative mRNA levels of PKCa, PKCbII, PKCe, and PKCh were analyzed in livers from WT and PKCd 2/2 mice fed a control or MCD diet. Relative mRNA levels of the PKC isoforms was not affected by the MCD diet in WT mice; however, a significant reduction in PKCa and PKCe mRNA was observed in PKCd 2/2 mice (Fig. 6A ). Membrane and cytosolic protein content of PKCa, PKCbII, PKCe, and PKCh was also assessed. Similar changes in PKC isoform membrane and cytosolic protein content were observed in MCD fed WT and PKCd 2/2 mice, except for in the MCD fed PKCd 2/2 mice where there was an 88% increase in PKCbII cytosolic protein content and a block in the reduction of PKCe membrane protein content (Fig. 6B) . Taken together, these results suggest that subtle compensatory changes in the expression or activation of PKC isoforms occur in the liver of PKCd 2/2 mice.
Discussion
Mice fed an MCD diet develop an unusual form of lipodystrophy, weight loss that is accompanied with hepatic steatosis. Hypoglycemia and enhanced whole body insulin sensitivity are additional limitations in the MCD diet model. The weight loss observed in MCD diet fed mice is associated with increased metabolic rate without an increase in food consumption and is associated with suppression in hepatic SCD-1 expression [24] . Indeed, we observed MCD diet-induced weight loss in all mice studied and a profound suppression in hepatic SCD-1 expression in WT and PKCd 2/2 mice. MCD diet-induced weight loss is also accompanied by a reduction in fat pad weight relative to body weight which leads to a redistribution of TG stores to the liver.
Interestingly, PKCd
2/2 mice on the control diet weighed ,18% less than their WT littermates. The control diet is enriched in sucrose and thus is lipogenic [25] . The reduction in weight gain observed in the PKCd 2/2 mice on the control diet is consistent with the results observed by Bezy et. al. with PKCd 2/2 mice fed a high fat diet [14] .
The mechanism of MCD diet-induced hepatic steatosis is thought to involve an upregulation in the uptake of fatty acids derived from fat coupled with a reduction in the export of VLDL without any major changes to b-oxidation of fatty acids [26] . In the present study the MCD diet-induced reduction in fat pad weight relative to body weight and serum TG and NEFA levels was not observed in PKCd 2/2 mice, suggesting that subtle changes to lipid metabolism occurs in PKCd 2/2 mice. Consistent with this conclusion, we observed changes in hepatic steatosis and TG and in the expression of genes involved in b-oxidation of fatty acids and VLDL export in four week MCD diet fed PKCd 2/2 mice. Consistent with these observations, PKCd has been shown in high fat fed mice to regulate the induction of hepatic genes involved in lipogenesis [14, 15] . In agreement with these studies, we observed changes in the expression of genes involved in lipogenesis, b-oxidation of fatty acids, and VLDL export in fatty acid treated hepatocytes isolated from PKCd 2/2 mice compared to those isolated from WT mice.
A major finding in the present study was the ability of PKCd to regulate oxidative stress in the liver of MCD diet fed mice. Oxidative stress is a defining characteristic of NASH [27] and is observed in the MCD diet model of steatohepatitis [18] . Our data showed significant reductions in oxidative stress as measured by 4-HNE staining, the detection of TBARS, and a reduction in NADPH oxidase activity in PKCd 2/2 mice. These data are consistent with the proposed role of PKCd in antioxidant induction of defensive mechanisms [28] . Elevated oxidative stress in MCD diet fed mice is associated with the induction of components of the NADPH oxidase complex (Nox2, p22 phox , p47 phox , and p67 phox ) [29] . In the present study, we also observed increases in mRNA and protein expression of components of the NADPH oxidase complex in MCD diet fed WT mice. Unexpectedly, we observed significant increases in mRNA expression of Nox2, p22 phox , p47 phox , and p67 phox and protein expression of p22 phox and p47 phox in control fed PKCd 2/2 mice. Further, the MCD diet was without effect on induction of components of the NADPH oxidase complex in PKCd 2/2 mice. These results lead us to speculate that basal oxidative stress is elevated in PKCd mice, which may play a protective role in the MCD diet fed PKCd 2/2 mice. However, we found that NADPH oxidase activity was not upregulated in PKCd 2/2 mice fed the control diet. Thus, the up regulation of NADPH oxidase subunit mRNA and protein in the PKCd 2/2 mice does not lead to elevated NADPH oxidase function. To further investigate NADPH activation in MCD diet fed mice, we examined the translocation of p47 phox , the organizing subunit of the Nox2 NADPH oxidase complex. We observed that MCD diet stimulation of p47 phox translocation was impaired in 
PKCd
2/2 mice which is consistent with our data on NADPH oxidase activity. The mechanism by which p47 phox translocation is impaired in PKCd 2/2 mice is not known. However, PKCd is one of a number of kinases (e.g. other PKC isoforms, ERK1/2, p38 MAPK, Pak1, and Akt) known to phosphorylate p47 phox and regulate translocation [30] . In addition, Nox2 NADPH oxidase activity is modulated by PKC phosphorylation of Nox2 [31] and possibly by phosphorylation of p22 phox and p67 phox [30] . Apoptosis is a characteristic marker for the progression of steatosis to steatohepatitis. It is associated with an inflammatory response and is thought to play a critical role in the development of fibrosis [32, 33] . The use of caspase inhibitors to reduce the development of NASH and lessen the severity of the MCD diet indicates that apoptosis plays an important role in MCD dietinduced steatohepatitis [34, 35] . We observed a significant increase in hepatocyte apoptosis in mice fed a MCD diet for eight weeks compared to four weeks. Hepatocyte apoptosis was reduced in PKCd 2/2 mice compared to WT mice fed a MCD diet. Consistent with the proposed role of caspases in MCD dietinduced hepatocyte apoptosis, we found that caspase activation was blocked in liver of PKCd 2/2 mice compared to WT mice. This result is in agreement with other studies linking PKCd and caspase activation [36] . We did not observe major differences in cell cycle gene expression between WT and PKCd 2/2 mice fed a MCD diet. However, a significant reduction in the expression of pro-apoptotic genes in PKCd 2/2 mice compared to WT mice fed a MCD diet was observed. These results are consistent with our findings that PKCd regulates fatty acid-induced cell death in a cellular model of steatohepatitis [18] .
In contrast to our findings on apoptosis and caspase activation in the liver, we found that serum ALT, a marker of liver injury, did not differ between WT and PKCd 2/2 mice fed a MCD diet. Thus, a lack of congruency was observed between serum ALT levels and oxidative stress and apoptosis in MCD diet fed PKCd 2/2 mice. A lack of congruency in serum ALT levels in MCD diet fed mice has also been observed by others. For example, a complete block in MCD dietinduced hepatic NADPH oxidase activity has been observed in the presence of significantly elevated serum ALT levels are in TLR4 2/2 mice [29] , while a lack of congruency between serum ALT and proinflammatory gene expression and development of fibrosis has been observed in caspase-1 2/2 MCD diet fed mice [37] . Finally, a recent study in NAFLD patients observed a lack of correlation between serum liver enzymes including ALT and changes in steatosis, inflammation, hepatocyte ballooning, or fibrosis stage over time [38] .
Our observation that gene expression of TNFa, MIP1a/CCL3, PAI-1, IL1a, and IL1b which have been shown to be upregulated in the liver of MCD diet fed rodents [39] [40] [41] did not differ in the liver between PKCd 2/2 and WT mice, even though a reduction in histological inflammation score in PKCd 2/2 mice compared to WT mice was observed, suggests that PKCd plays a role in steatohepatitis progression downstream from the induction of inflammation. Consistent with this conclusion are results demonstrating that TNFa and MCP-1 activate PKCd [20, 42] and that lipid-induced PKCd activation in the liver is associated with increases in serum levels of MCP-1 [9] . Alternatively, the uncoupling of elevated proinflamatory gene expression and a reduction in histological inflammation score in PKCd 2/2 mice compared to WT mice could be due to differential polarization of resident macrophages (Kupffer cells) or infiltrated macrophages [43] and/or changes to immune cell dynamics in the liver [44] .
A major surprise in our study was that no difference in Masson's trichrome and Sirius Red staining of liver sections was observed between WT and PKCd 2/2 mice fed the MCD diet for eight weeks. Consistent with our staining results, we observed no differences in the expression of hepatic fibrosis genes known to be upregulated in MCD diet fed mice [45] . Thus, the results from our model indicate that reducing hepatic inflammation and oxidative stress does not ameliorate hepatic fibrosis development. However, it possible that the degree of inflammation and oxidative stress reduction we observed may have led to a reduction in fibrosis at a later time point in the MCD diet feeding.
Our results do not agree with the recent study by Lee et al. [46] in which rottlerin and a PKCd short peptide inhibitor blocked fibrogenic gene expression and fibrosis in mice fed a MCD diet for 3 weeks and treated with LPS for 6 h. However, the LPS treatment lead to significant increases (from 8-to 15-fold) in hepatic TGF-b, a-SMA, and pro-collagen-1 a1 mRNA expression compared to that observed in the untreated, MCD diet fed mice. Further, Masson's trichrome staining was observed in the 6 h LPS treated, MCD diet fed mice but not in the untreated, MCD diet fed mice. Thus, fibrosis development appears to be an acute response in the LPS-treated, MCD fed mice compared to fibrosis development in the present study which was observed in mice fed the MCD diet for 8 weeks. Finally, the LPS independent effects of PKCd on key pathophysiological features of NASH are not known in the LPS-treated, MCD diet model of NASH. Further, given that there are key pathophysiological features in human patients with NASH (obesity and whole body insulin resistance) which are not present in the MCD diet model of NASH, it is possible that PKCd deletion in the context of obesity and whole body insulin resistance may reduce fibrosis.
A limitation in our study is that our findings are based upon a whole body knockout of PKCd. The development of NASH is a complex pathophysiological process that requires cross-talk between the liver and other major organ systems such as adipose tissue [47] . Thus, the role of PKCd in key aspects of the pathophysiology of NASH in the liver and adipose tissue will require tissue-specific knockout models.
In conclusion, we have shown that PKCd regulates lipid metabolism, oxidative stress, and apoptosis, key aspects of the pathophysiology of MCD diet induced steatohepatitits in mice. Our key finding that PKCd regulates apoptosis in MCD diet fed mice suggest that our results may have relevance to the human condition where apoptosis is being targeted to treat NASH [48] . In addition, our studies using primary hepatocytes suggest that PKCd modulates the direct effect of fatty acids on lipid metabolism expression. Finally, the data presented here suggest that increased PKCd protein levels and activation may be involved in the development of NASH. Figure S1 Hepatic ER stress activation. Liver tissue from mice on control or MCD diets for four weeks was pulverized under liquid N 2 , and lysed in detergent containing buffer. A. Total cell lysate (60 mg of protein) from liver tissue was analyzed by immunoblotting for IRE1, phospho-PERK, phospho-JNK, BiP, and aTubulin expression. B. Quantitation of the immunoreactive bands minus background is shown as the means +/2 SE (*, p,0.05 versus control diet). (TIF)
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